User profiles for Dejan Radovanovic

Dejan Radovanovic

Attending Physician, Pulmonary Unit, Luigi Sacco University Hospital, University of Milan …
Verified email at unimi.it
Cited by 2500

Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study

S Aliberti, D Radovanovic, F Billi… - European …, 2020 - Eur Respiratory Soc
Patients with coronavirus disease 2019 (COVID-19) pneumonia can develop hypoxaemic
acute respiratory failure (hARF) with the need for positive end-expiratory pressure (PEEP). …

[HTML][HTML] A comprehensive approach to lung function in bronchiectasis

D Radovanovic, P Santus, F Blasi, G Sotgiu… - Respiratory …, 2018 - Elsevier
Background International guidelines recommend simple spirometry for bronchiectasis patients.
However, pulmonary pathophysiology of bronchiectasis is very complex and still poorly …

Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia

…, M Parati, M Villani, D Radovanovic… - Open forum …, 2020 - academic.oup.com
Background In hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia,
progression to acute respiratory failure requiring invasive mechanical ventilation (MV) is …

Helmet CPAP to treat acute hypoxemic respiratory failure in patients with COVID-19: a management strategy proposal

D Radovanovic, M Rizzi, S Pini, M Saad… - Journal of clinical …, 2020 - mdpi.com
Since the beginning of March 2020, the coronavirus disease 2019 (COVID-19) pandemic
has caused more than 13,000 deaths in Europe, almost 54% of which has occurred in Italy. …

Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study

M Viecca, D Radovanovic, GB Forleo… - Pharmacological research, 2020 - Elsevier
Patients affected by severe coronavirus induced disease-2019 (Covid-19) often experience
hypoxemia due to alveolar involvement and endothelial dysfunction, which leads to the …

Prevalence and etiology of community-acquired pneumonia in immunocompromised patients

…, G Sotgiu, A Gramegna, D Radovanovic… - Clinical Infectious …, 2019 - academic.oup.com
Dejan Radovanovic , Dejan Radovanovic … Marta Francesca Di Pasquale, Giovanni
Sotgiu, Andrea Gramegna, Dejan Radovanovic, Silvia Terraneo, Luis F Reyes, Jan Rupp, Juan …

Severity of respiratory failure at admission and in-hospital mortality in patients with COVID-19: a prospective observational multicentre study

P Santus, D Radovanovic, L Saderi, P Marino… - BMJ open, 2020 - bmjopen.bmj.com
Objectives COVID-19 causes lung parenchymal and endothelial damage that lead to hypoxic
acute respiratory failure (hARF). The influence of hARF severity on patients’ outcomes is …

[HTML][HTML] PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response

…, E Ippolito, S Di Maggio, L Loreggian, D Radovanovic… - JCI insight, 2021 - ncbi.nlm.nih.gov
A substantial proportion of patients who have recovered from coronavirus disease-2019 (COVID-19)
experience COVID-19–related symptoms even months after hospital discharge. We …

A systematic review on tracheostomy decannulation: a proposal of a quantitative semiquantitative clinical score

P Santus, A Gramegna, D Radovanovic… - BMC Pulmonary …, 2014 - Springer
Background Tracheostomy is one of the most common surgical procedures performed in
critical care patient management; more specifically, ventilation through tracheal cannula allows …

[HTML][HTML] Characteristics and outcomes in hospitalized COVID-19 patients during the first 28 days of the spring and autumn pandemic waves in Milan: an observational …

D Radovanovic, S Pini, E Franceschi, M Pecis… - Respiratory …, 2021 - Elsevier
Background The therapeutic approach to COVID-19 and healthcare system preparedness
improved during 2020. We compared characteristics and outcomes of hospitalized COVID-19 …